The AMD Experts
We’re on a mission to eliminate blindness caused by age-related macular degeneration (AMD). Our vision is bold but well within reach.
MacuLogix® is a company that equips eye care professionals with the technology, tools, and education needed to help identify and manage AMD patients early, before irreversible vision loss has occurred. We can help you deliver better patient care with the scientifically validated AdaptDx Pro®.
Help us save the eyesight of millions by making early functional testing for AMD a routine part of eye care for your aging patients.
Bill McPhee, the President and CEO of MacuLogix, shares his personal story of why he joined the company and adopted its vision of eliminating blindness caused by AMD.
By being able to test more patients, we’ll ultimately uncover more macular degeneration. That’s good for patients. And I think we all need to realize that what’s good for our patients winds up being good for our practices.
Latest News & Upcoming EventsView More
Integrating new technology into your practice can be a challenge, but Theia is here to share some secrets that can lead to success.
The Internet of Things (IoT) accelerates medical advancements, bringing much-appreciated improvements for patients and providers alike. Here are six ways in which IoT technology, such as the AdaptDx Pro guided by Theia, has recently benefited the medical field.
Plenty can change in the months between comprehensive exams, especially for our aging patients. Dr. Tammy Tully sleeps better at night knowing that she's detecting AMD as early as possible to prescribe proactive treatment to help preserve their vision.
Put Our Expertise to Work
Testing with AdaptDx Pro
AdaptDx Pro identifies impaired dark adaptation—the earliest warning sign of AMD.
Each AdaptDx Pro purchase is supported by our AMD Excellence Program® to help you achieve your patient care and practice revenue goals.